ORAGENICS, INC. (OGEN)

Every figure this model derived for OGEN, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2023-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 127,519 PaymentsToAcquirePropertyPlantAndEquipment 2022-12-31
cash 7,864,184 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 5,492,501 AssetsCurrent 2026-06-30
current liabilities 1,798,181 LiabilitiesCurrent 2023-12-31
equity 3,670,634 StockholdersEquity 2026-06-30
revenue 37,653 RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up OGEN on one particular measure came for.

RatioValue
current ratio3.05
current ratio reported3.05
deferred revenue growth-100.0
revenue growth-71.37
revenue growth per share-71.37
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about OGEN's figures. Written by the derivation as it ran, not added afterwards.